Effect of tegaserod on gut transit in male and female subjects

Neurogastroenterology and Motility

Volumn 17, Issue 6, 2005, Pages 821-826

  Degen, L ^a   Petrig, C ^a   Studer, D ^a   Schroller, S ^a   Beglinger, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Gastric emptying; Motility; Serotonin

Indexed keywords

PLACEBO; PROKINETIC AGENT; TEGASEROD;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL TRACT SCINTISCANNING; HUMAN; INTESTINE TRANSIT TIME; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SMALL INTESTINE; STOMACH EMPTYING;

CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMANS; INDOLES; MALE; SEROTONIN AGONISTS; SEX CHARACTERISTICS;

EID: 28544436497     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2005.00715.x     Document Type: Article

References (27)

1. Farthing MJ. New drugs in the management of the irritable bowel syndrome. Drugs 1998; 56: 11-21.
2. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998; 115: 370-80.
3. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 2120-37.
4. Foxx-Orenstein AE, Jin JG, Grider JR. 5-HT4 receptor agonists and delta-opioid receptor antagonists act synergistically to stimulate colonic propulsion. Am J Physiol 1998; 275: G979-83.
5. Foxx-Orenstein AE, Kuemmerle JF, Grider JR. Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology 1996; 111: 1281-90.
6. Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000; 118: 463-8.
7. Degen L, Matzinger D, Merz M, Appel-Dingemanse S, Osborne S, Luchinger S et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001; 15: 1745-51.
8. Muller-Lissner SA, Fumagalli I, Bardhan KD et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001; 15: 1655-66.
9. Novick J, Miner P, Krause R et al. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002; 16: 1877-88.
10. Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut 1996; 39: 299-305.
11. Camilleri M, Colemont LJ, Phillips SF et al. Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol 1989; 257: G284-90.
12. Stiviand T, Camilleri M, Vassallo M et al. Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991; 101: 107-15.
13. Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, Proano M. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci 1991; 36: 609-15.
14. Greydanus MP, Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM. Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology 1990; 99: 158-64.
15. De Ponti F, Tonini M. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs 2001; 61: 317-32.
16. Gershon MD. Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004; 20 (Suppl. 7): 3-14.
17. Corsetti M, Tack J. Tegaserod: a new 5-HT(4) agonist in the treatment of irritable bowel syndrome. Expert Opin Pharmacother 2002; 3: 1211-8.
18. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000; 95: 2698-709.
19. Jin JG, Foxx-Orenstein AE, Grider JR. Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors. J Pharmacol Exp Ther 1999; 288: 93-97.
20. Davies GJ, Crowder M, Reid B, Dickerson JWT. Bowel function measurements of individuals with different eating patterns. Gut 1986; 27: 164-9.
21. Hinds JP, Stoney B, Wald A. Does gender or the menstrual cycle affect colonic transit? Am J Gastroenteiol 1989; 84: 123-6.
22. Madsen JL. Effects of gender, age, and body mass index on gastrointestinal transit times. Dig Dis Sci 1992; 37: 1548-53.
23. Meier R, Beglinger C, Dederding P et al. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol Motil 1995; 7: 235-9.
24. Lawaetz O, Dige-Petersen H. Gastric emptying of liquid meals: A study in 88 normal persons. Ann Chir Gynaecol 1989; 78: 267-76.
25. Turnbull GK, Thompson DG, Day S, Martin J, Walker E, Lennard-Jones JE. Relationship between symptoms, menstrual cycle and orocaecal transit in normal and constipated women. Gut 1989; 30: 30-34.
26. Horowitz M, Maddern GJ, Chatterton BE et al. The normal menstrual cycle has no effect on gastric emptying. Br J Obstet Gynaecol 1985; 92: 743-6.
27. Wald A, Van Thiel DH, Hoechstetter L et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80: 1497-500.